NYSE Euronext, a leading global operator of financial markets and provider of trading technologies, announced this week that NYSE Liffe, its global derivaPARA_BREAK_SENTINEL_9f8e7d6c NYSE Euronext, a leading global operator of financial markets and provider of trading technologies, announced this week that NYSE Liffe, its global derivatives business division, secured its first China-headquartered brokerage client through its Hong Kong subsidiary: GF Futures (Hong Kong) Co. The brokerage became a trading member of NYSE Liffe on 14 July. “This means that through their connection to NYSE Liffe, GF Futures (Hong Kong) is the first Chinese broker to give its customer base direct access to our international trading network out of Hong Kong,” commented a delighted Garry Jones, Group EVP and Head of Global Derivatives at NYSE Liffe. The news further reinforces the importance NYSE Euronext places on expanding its business in Asia as trading volumes in the region ramp up. The group now has representative offices in Beijing, Hong Kong, Singapore and Tokyo. Speaking about his firm’s newly acquired membership status, Dr Xiao Cheng, General Manager of GF Futures, said that the firm was “honoured” to be the first Chinese broker to join NYSE Liffe. “This will give us a better understanding of the European market,” said Cheng, adding that the membership would offer its customers “access to the international market as well as being a major step to [sic] the internationalization of GF Group”.
Yen carry trade risks mount
Hedge funds and other leveraged investors face renewed risks from the yen carry trade as Japan moves further away from decades of…
More
Valour launches first crypto hedge fund using Neuronomics AI strategy
Valour, the digital asset investment products subsidiary of DeFi Technologies, has launched its first hedge fund as it expands beyond…
More
SocGen targets strong prime brokerage growth
Societe Generale is planning to significantly expand its prime brokerage business as part of Chief Executive Officer Slawomir Krupa's…
More